Hoth Therapeutics, Inc. (HOTH): Price and Financial Metrics
HOTH Price/Volume Stats
| Current price | $0.81 | 52-week high | $1.73 |
| Prev. close | $0.77 | 52-week low | $0.58 |
| Day low | $0.73 | Volume | 155,600 |
| Day high | $0.82 | Avg. volume | 1,356,315 |
| 50-day MA | $0.85 | Dividend yield | N/A |
| 200-day MA | $0.98 | Market Cap | 5.59M |
HOTH Stock Price Chart Interactive Chart >
Hoth Therapeutics, Inc. (HOTH) Company Bio
Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.
HOTH Price Returns
| 1-mo | -2.50% |
| 3-mo | -16.49% |
| 6-mo | -12.92% |
| 1-year | -40.00% |
| 3-year | -95.68% |
| 5-year | -99.38% |
| YTD | -43.75% |
| 2023 | -81.54% |
| 2022 | -52.72% |
| 2021 | -72.16% |
| 2020 | -61.71% |
| 2019 | N/A |
Loading social stream, please wait...